INTEGRA LIFESCIENCES HOLDINGS CORP Payments to Acquire Investments
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Payments to Acquire Investments of $30.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for the quarter ending 2026-06-30 was $30.98M, a 1962.32% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for the quarter ending 2025-12-31 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for the quarter ending 2025-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for fiscal 2025 was $8.50M, a 82.65% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for fiscal 2024 was $49.00M, a 49.87% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for fiscal 2023 was $32.69M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments to acquire investments for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $30.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $30.98M 10-Q · filed 2026-07-29 | $30.98M derived: sum of 3 quarters · filed 2026-07-29 | $30.98M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $0.00 derived: sum of 3 quarters · filed 2026-05-05 | $1.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $1.50M derived: sum of 3 quarters · filed 2026-07-29 | $8.50M 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.50M derived: sum of 2 quarters · filed 2026-07-29 | $8.50M 10-Q · filed 2025-10-30 | $8.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $8.50M 10-Q · filed 2026-07-29 | $8.50M derived: sum of 3 quarters · filed 2026-07-29 | $8.50M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $7.00M 10-Q · filed 2026-05-05 | $7.00M derived: sum of 2 quarters · filed 2026-05-05 | $7.00M derived: sum of 3 quarters · filed 2026-05-05 | $17.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $10.50M derived: sum of 3 quarters · filed 2026-02-26 | $49.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.50M derived: sum of 2 quarters · filed 2025-10-30 | $49.00M 10-Q · filed 2025-10-30 | $81.69M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $10.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $49.00M 10-Q · filed 2025-07-31 | $81.69M derived: sum of 3 quarters · filed 2026-02-26 | $81.69M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $38.50M 10-Q · filed 2025-05-05 | $71.19M derived: sum of 2 quarters · filed 2026-02-26 | $71.19M derived: sum of 3 quarters · filed 2026-02-26 | $71.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $32.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $32.69M derived: sum of 2 quarters · filed 2026-02-26 | $32.69M derived: sum of 3 quarters · filed 2026-02-26 | $32.69M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $0.00 derived: sum of 2 quarters · filed 2024-11-04 | $0.00 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $0.00 10-Q · filed 2024-07-29 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |